在这项工作中,合成了一系列苯甲酰溴衍生物,并用作合成取代的咪唑并[1,2- a ]吡啶的关键中间体。首先,在微波辐射的辅助下,通过苯乙酮的溴化反应获得苯甲酰溴分子,在15分钟的反应中获得产物4a-v,产率在50%至99%之间。随后,这些分子与2-氨基吡啶共轭,产生了咪唑并[1,2- a ]吡啶衍生物(7a-v)在60秒的反应中产率为24%至99%。相对于通过更繁琐的方法(如热辅助和机械辅助路线)获得的产量,确定了更高的产量。根据取代基的性质,在紫外线激发下观察到电磁光谱的紫色和蓝色区域中的强烈发光发射。这种对环境友好的方法有望构成一类重要的有机化合物,用于开发生物标志物,光化学传感器和医学应用。
Mild and Regioselective Three‐component Heteroarylation‐Nitration of Alkenes with Imidazo[1,2‐
<i>a</i>
]pyridines and
<i>tert</i>
‐Butyl Nitrite
作者:Jie Zhang、Shentong Xie、Ping Liu、Peipei Sun
DOI:10.1002/adsc.202000078
日期:2020.5.26
An efficient and regioselective three‐component heteroarylation‐nitration of alkenes with imidazo[1,2‐a ]pyridines and tert ‐butyl nitrite has been developed. The process tolerants a variety of functional groups under mild conditions in the absence of catalysts and additives to give nitro functionalized imidazo[1,2‐a ]pyridine derivatives in moderate to good yields. The reaction is also applicable
已经开发了一种高效的区域选择性烯烃三元杂芳基硝化硝化反应,该硝化反应包括咪唑并[1,2- a ]吡啶和亚硝酸叔丁酯。在没有催化剂和添加剂的条件下,该工艺可在温和条件下耐受各种官能团,从而以中等至良好的收率得到硝基官能化的咪唑并[1,2- a ]吡啶衍生物。该反应也适用于其他一些氮杂杂环。
Direct one-pot synthesis of zolimidine pharmaceutical drug and imidazo[1,2-a]pyridine derivatives via I2/CuO-promoted tandem strategy
2-a]pyridines from easily available starting materials: Aromaticketones, α,β-unsaturatedketones, β-keto esters and 2-aminopyridines. The present reaction proceeded well in MeOH under the media of I2/CuO. By using this method, the marketed drug zolimidine could be prepared easily with 95% yield. All these target products were characterized by NMR, HRMS and IR spectra. Furthermore, the target compound 3fa was determined
Solvent and catalyst‐free synthesis of imidazo[1,2‐a]pyridines by grindstone chemistry
作者:Kumar Godugu、Chinna Gangi Reddy Nallagondu
DOI:10.1002/jhet.4164
日期:2021.1
The present work describes the solvent and catalyst‐free synthesis of imidazo[1,2‐a]pyridines in excellent to nearly quantitative yields from 2‐aminopyridines and a wide variety of ω‐bromomethylketones using a grindstone procedure at 25°C to 30°C for 3 to 5 minutes. The absolute structure of the compound, 2‐(3‐bromophenyl)‐7‐methylimidazo[1,2‐a]pyridine is determined by X‐ray crystallography. This
[EN] SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR<br/>[FR] LIGANDS SÉLECTIFS DU RÉCEPTEUR D'ANDROSTANE CONSTITUTIF HUMAIN
申请人:USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I
公开号:WO2020221380A1
公开(公告)日:2020-11-05
The present invention provides a structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl. The novel compounds are useful in a method of prevention or treatment of a condition which is mediated by the action, or by loss of action, of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention thus provides the novel compounds for medicinal use, as well as pharmaceutical composition containing said compounds. (I)
A rhodium-catalyzed annulation between 2-arylimidazo[1,2-a]pyridines and alkynes was developed, leading to pyrido[1,2-a]benzimidazole derivatives in moderate to excellent yields.